Research News and Research

RSS

Onconova Therapeutics to present Ex-RAD radioprotectant data at RRS Annual Meeting

Onconova Therapeutics, Inc. is presenting new data in five posters and an oral presentation this week summarizing several studies with the company's radioprotectant Ex-RAD- at the 56th Annual Meeting of the Radiation Research Society (RRS), September 25-29 in Maui, Hawaii.

28 Sep 2010

Report: Workers' medical costs projected to jump next year by more than 12 percent

Health care bills for an average employee are slated to climb more than $486 next year, a 12.4 percent increase from this year, according to a study by Hewitt Associates.

28 Sep 2010

Southridge, Curaxis Pharmaceutical announce $25 million equity purchase agreement

Stephen Hicks, Chairman and CEO, of Southridge LLC and Patrick S. Smith, President and Chief Executive Officer of Curaxis Pharmaceutical Corp , jointly announced a $25 million equity purchase agreement with Southridge Partners II, an institutional investor.

28 Sep 2010

Study may provide new developing approaches to treat age-related osteoporosis

Aging disrupts the balance between bone formation and bone destruction, resulting in osteoporosis, which is characterized by reduced bone mass and increased risk of fracture. Recent data have suggested that this imbalance is a result of a decrease in formation of bone forming osteoblast cells from mesenchymal cells upon aging.

28 Sep 2010

Scientists identify gene associated with common migraines

An international study led by scientists at Universit- de Montr-al and University of Oxford, has identified a gene associated with common migraines. Their findings show that a mutation in the KCNK18 gene inhibits the function of a protein called TRESK. TRESK normally plays a key role in nerve cell communication. Published today in Nature Medicine, this study may have implications for people who suffer from recurrent headaches, which include more than six million Canadians.

28 Sep 2010

Opinions: U.S. food aid; MDGs; Contraceptive access, technology; U.S. AIDS funding; Foreign assistance reform

"The best way to help the millions of hungry people in countries that receive food aid get rid of their corrupt and incompetent rulers - and to ensure that their children will never go hungry in future — is to starve them now. That will turn them into raging, unstoppable anti-government regime changers," writes Nation Media Group Executive Editor Charles Onyango-Obbo in an East African opinion piece.

28 Sep 2010

C-CCNE receives grant to improve cancer treatment using nanotechnology

The National Cancer Institute has awarded a five-year, $13.6 million grant to the University of North Carolina at Chapel Hill's Carolina Center of Cancer Nanotechnology Excellence (C-CCNE) based at the UNC Lineberger Comprehensive Cancer Center, for research to improve the diagnosis and treatment of cancer through applying/using advances in nanotechnology.

28 Sep 2010

MDG summit: Funding the Global Fund; Arab world's 'own challenges'

BusinessDay reports that following last week's Millennium Development Goal summit at the U.N. in New York, advocates "have called on rich nations to double their pledges to the Global Fund to Fight AIDS, Tuberculosis and Malaria, saying it desperately needs more money if the world is to meet the health-related Millennium Development Goals by 2015."

28 Sep 2010

Many adults skip vaccines because of costs

The New York Times' Patient Money column examines the importance of vaccines for adults.

28 Sep 2010

USC, Las Encinas Hospital to study on schizophrenia, bipolar disorder in younger, older adults

Schizophrenia and bipolar disorder affect 3% to 4% of the world's population, or about 222 million adults worldwide. In the United States, bipolar disorder affects about 5.7 million adult Americans 18 and older. Bipolar disorder, or manic depression, is a serious brain disorder that causes extreme shifts in mood, energy and functioning. People with the disorder experience episodes of mania and depression that can last from days to months. These symptoms usually begin in late adolescence, but can begin in early childhood or as late as a person's 40s or 50s. There is a strong genetic component related to bipolar disorder.

28 Sep 2010

HHS pumps up rhetoric but eases rules on health insurance for kids

Politico reports that the administration "is taking health insurers to task again, this time for choosing to no longer sell plans intended to cover sick children." Insurers "have said in recent weeks that they would stop selling 'child only' insurance plans because the overhaul requires them to accept all applicants, even if they apply for coverage at the last minute before treatment." In a letter to industry groups, Health and Human Services Secretary Kathleen Sebelius highlighted the "plight of millions of parents who desperately want to provide health coverage and critical treatments" in the face of insurer decisions.

28 Sep 2010

Michael J. Fox Foundation launches PPMI clinical study to identify Parkinson's disease biomarkers

The Michael J. Fox Foundation has launched the Parkinson's Progression Markers Initiative (PPMI), the first ever large scale clinical study exclusively focused on identifying and validating Parkinson's disease biomarkers.

28 Sep 2010

IAVI investigators awarded grant to examine antibodies that neutralize HIV virus

A team of investigators headed by International AIDS Vaccine Initiative Investigator Pascal Poignard has been awarded a major grant from the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health to investigate the biological mechanisms underlying the generation of broadly neutralizing antibodies by HIV positive individuals.

28 Sep 2010

Depression and anxiety disorders common in loved ones of breast cancer patients: Study

Earlier studies have shown that women living with breast cancer are at a risk of depression but new studies have shown that their partners are at a similar risk. The study looked at more than a million men enrolled in a nationwide Danish health registry followed for 13 years.

28 Sep 2010

Government health IT market poised to grow dramatically

The Washington Post reports on the growing field of government health IT jobs.

28 Sep 2010

Survey: 43% of employees think health benefits are more important than higher wages

Forty-three percent of employees think health benefits are more important than higher wages, according to the recent "Getting Paid In America" survey conducted by the American Payroll Association.

28 Sep 2010

Doctors face more unpaid bills during recession; Maine MDs rebel against AMA

Some patients, struggling in the bad economy, aren't paying their doctors. "The problems are especially acute for primary care doctors, but specialists are not immune," the Pittsburgh Business Times reports.

28 Sep 2010

Community health centers help those without insurance

In 2001, a Charleston, W.Va., a hospital and three community health centers set up a Community Access Program to help give low-income residents a primary health care system in the hopes of lowering emergency room care. The program has enrolled 5,000 people and "cut their hospital use in half," the Charleston Gazette reports.

28 Sep 2010

Novel therapies for HCV treatment can precipitate several changes: Report

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the launch of novel therapies for the treatment of Hepatitis C Virus (HCV), including Vertex/Johnson & Johnson/Mitsubishi Tanabe's telaprevir and Merck's boceprevir, will precipitate several changes in HCV treatment.

28 Sep 2010

Genomics obtains worldwide rights to The Garvan Institute of Medical Research's methylation DNA biomarkers

Clinical Genomics Pty. Ltd (Sydney, Australia) and The Garvan Institute of Medical Research (Sydney, Australia) today announced that they have entered into a license agreement in relation to novel biomarkers discovered by scientists at the Garvan Institute. Under the terms of the agreement, Clinical Genomics obtains worldwide exclusive rights to the Garvan's proprietary cancer associated methylation DNA biomarkers for the diagnosis and or treatment of colorectal cancer.

28 Sep 2010

Research News and Research

Onconova Therapeutics to present Ex-RAD radioprotectant data at RRS Annual Meeting

Report: Workers' medical costs projected to jump next year by more than 12 percent

Southridge, Curaxis Pharmaceutical announce $25 million equity purchase agreement

Study may provide new developing approaches to treat age-related osteoporosis

Scientists identify gene associated with common migraines

Opinions: U.S. food aid; MDGs; Contraceptive access, technology; U.S. AIDS funding; Foreign assistance reform

C-CCNE receives grant to improve cancer treatment using nanotechnology

MDG summit: Funding the Global Fund; Arab world's 'own challenges'

Many adults skip vaccines because of costs

USC, Las Encinas Hospital to study on schizophrenia, bipolar disorder in younger, older adults

HHS pumps up rhetoric but eases rules on health insurance for kids

Michael J. Fox Foundation launches PPMI clinical study to identify Parkinson's disease biomarkers

IAVI investigators awarded grant to examine antibodies that neutralize HIV virus

Depression and anxiety disorders common in loved ones of breast cancer patients: Study

Government health IT market poised to grow dramatically

Survey: 43% of employees think health benefits are more important than higher wages

Doctors face more unpaid bills during recession; Maine MDs rebel against AMA

Community health centers help those without insurance

Novel therapies for HCV treatment can precipitate several changes: Report

Genomics obtains worldwide rights to The Garvan Institute of Medical Research's methylation DNA biomarkers

A guide to advancing biotherapeutic research eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence